Real-world monitoring of circulating tumor DNA reliably predicts cancer recurrence in patients with resected stages I-III colorectal cancer

被引：2

作者：

Cohen, S. A. ^{[1
,2
]}

Kasi, P. M. ^{[3
]}

Aushev, V. N. ^{[4
]}

Hanna, D. L. ^{[5
]}

Botta, G. P. ^{[6
]}

Sharif, S. ^{[7
]}

Laliotis, G. ^{[4
]}

Sharma, S. ^{[4
]}

Sharma, V. ^{[8
]}

Alqahtani, A. ^{[9
]}

Chandana, S. R. ^{[10
]}

Kang, S. ^{[11
]}

Chakrabarti, S. ^{[12
]}

Somer, B. G. ^{[13
]}

Kasi, A. ^{[14
]}

Dayyani, F. ^{[15
]}

Malla, M. ^{[16
]}

Jurdi, A. ^{[4
]}

Aleshin, A. ^{[4
]}

Kopetz, S. ^{[17
]}

机构：

[1] Univ Washington, Med Oncol, Seattle, WA USA

[2] Fred Hutchinson Canc Ctr, Seattle, WA USA

[3] New York Presbyterian Hosp, Englander Inst Precis Med, Oncol Hematol Dept, Weill Cornell Med, New York, NY USA

[4] Natera Inc, Oncol, Austin, TX USA

[5] USC Univ Southern Calif, Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[6] UCSD Moores Canc Ctr, Div Hematol Oncol, Med, La Jolla, CA USA

[7] Univ Iowa, Med Oncol, Holden Comprehens Canc Ctr, Iowa City, IA USA

[8] James Graham Brown Canc Ctr, Med Oncol, Louisville, KY USA

[9] Georgetown Univ, Ruesch Ctr Cure Gastrointestinal Canc, Lombardi Comprehens Canc Ctr, Med Oncol,Med Ctr, Washington, DC USA

[10] Canc & Hematol Ctr Western Michigan, Oncol Hematol Dept, Grand Rapids, MI USA

[11] Emory Univ, Oncol Hematol Dept, Winship Canc Inst, Atlanta, GA USA

[12] Med Coll Wisconsin, Med Oncol, Milwaukee, WI USA

[13] West Canc Ctr, Med Oncol, Germantown, TN USA

[14] KUMC Univ Kansas Med Ctr, Med Oncol, Kansas City, KS USA

[15] Univ Calif Irvine, Med Dept, Chao Family Comprehens Canc Ctr, Orange, CA USA

[16] West Virginia Univ, Hematol Oncol, Inst Canc, Morgantown, WV USA

[17] Univ Texas MD Anderson Canc Ctr, GI Med Oncol Dept, Houston, TX USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.457

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

319MO

引用

页码：S683 / S684

页数：2

共 50 条

[21] Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Scholer, Lone V.
Reinert, Thomas
Orntoft, Mai-Britt W.
Kassentoft, Christine G.
Arnadottir, Sigrid S.
Vang, Soren
Nordentoft, Iver
Knudsen, Michael
Lamy, Philippe
Andreasen, Ditte
Mortensen, Frank V.
Knudsen, Anders R.
Stribolt, Katrine
Sivesgaard, Kim
Mouritzen, Peter
Nielsen, Hans J.
Laurberg, Soren
Orntoft, Torben F.
Andersen, Claus L.
CLINICAL CANCER RESEARCH, 2017, 23 (18) : 5437 - 5445
[22] Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer
O'Donnell, Conor D. J.
Naleid, Nikolas
Siripoon, Teerada
Zablonski, Kevin G.
Storandt, Michael H.
Selfridge, Jennifer E.
Hallemeier, Christopher L.
Conces, Madison L.
Jethwa, Krishan R.
Bajor, David L.
Thiels, Cornelius A.
Warner, Susanne G.
Starlinger, Patrick P.
Atwell, Thomas D.
Mitchell, Jessica L.
Mahipal, Amit
Jin, Zhaohui
CANCERS, 2024, 16 (13)
[23] Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I-IV colorectal cancer
Fan, Wenhua
Xia, Zhiyuan
Chen, Rongrong
Lin, Dagui
Li, Fang
Zheng, Yang
Luo, Jiongyong
Xiong, Yuanyuan
Yu, Pengli
Gao, Wei
Gong, Yuhua
Zhang, Feiran
Zhang, Sen
Li, Liren
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[24] Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I-III colorectal cancer in Australia
Prabhakaran, Swetha
Kong, Joseph C.
Chin, Martin
Carne, Peter
Farmer, Chip
Skinner, Stewart
Warrier, Satish K.
Bell, Stephen
LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (08) : 2789 - 2796
[25] Intratumoral budding (ITB) predicts worse outcome in stage I-III colorectal cancer patients
Karamitopoulou, E.
Kondi-Pafiti, A.
Koelzer, V.
Karandrea, D.
Gennatas, K.
Patsouris, E.
Lugli, A.
Zlobec, I.
VIRCHOWS ARCHIV, 2011, 459 : S17 - S17
[26] Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer
Roufai, Diana Bello
Bidard, Francois-Clement
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
[27] REAL-WORLD RECURRENCE RATES OF COLORECTAL CANCER OVER TIME
Kunst, Natalia R.
Alarid-Escudero, Fernando
Aas, Eline
Coupe, Veerle
Kuntz, Karen M.
MEDICAL DECISION MAKING, 2020, 40 (01) : E227 - E228
[28] Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer.
Cohen, Stacey A.
Kasi, Pashtoon Murtaza
Aushev, Vasily N.
Hanna, Diana L.
Botta, Gregory P.
Sharif, Saima
Laliotis, Georgios I.
Sharma, Vivek R.
Alqahtani, Ali
Chandana, Sreenivasa R.
Kang, Sandra
Chakrabarti, Sakti
Somer, Bradley G.
Kasi, Anup
Dayyani, Farshid
Malla, Midhun
Jurdi, Adham A.
Liu, Minetta C.
Aleshin, Alexey
Kopetz, Scott
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 5 - 5
[29] Survival after recurrence of stage I-III breast, colorectal, or lung cancer
Hassett, Michael J.
Uno, Hajime
Cronin, Angel M.
Carroll, Nikki M.
Hornbrook, Mark C.
Fishman, Paul
Ritzwoller, Debra P.
CANCER EPIDEMIOLOGY, 2017, 49 : 186 - 194
[30] A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer
Shivji, Sameer
Cyr, David P.
Pun, Cherry
Duan, Kai
Sari, Aysegul
Tomin, Rossi
Ng, Deanna
Brar, Amanpreet
Zerhouni, Siham
Kennedy, Erin
Brar, Mantaj
Swallow, Carol J.
Conner, James
Kirsch, Richard
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (10) : 1340 - 1351

← 1 2 3 4 5 →